Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.47%
#2 Status Status +17.94%
#3 GoPlus Security GoPlus Security +14.03%
#4 Ontology Gas Ontology Gas +11.14%
#5 Fake World Assets Fake World Assets +9.28%
#6 DMT-NAT DMT-NAT +9.09%
#7 o1.exchange o1.exchange +7.20%
#8 Provenance Blockchain Provenance Blockchain +7.18%
#9 Nillion Nillion +7.03%
#10 Pons Pons +6.71%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Classifica tra le azioni #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Prezzo delle azioni
$0.1502
Ultima sincronizzazione: 2024-11-04
Capitalizzazione di mercato
$6.43M
Variazione (1 giorno)
-5.45%
Variazione (1 anno)
0.00%
Paese
US
Scambia Renalytix Plc (RNLX)

Categoria

Healthcare
Il prezzo RNLX con la capitalizzazione del mercato della B
Renalytix Plc Renalytix Plc
RNLX
$0.1502
Capitalizzazione di mercato di Renalytix Plc(RNLX)
Capitalizzazione di mercato: $6.43M
A partire dal August 2026, Renalytix Plc ha una capitalizzazione di mercato pari a $6.43M. Questo rende Renalytix Plc la 33998th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Renalytix Plc dal 2020 al 2026
RNLX in paragone con la classifica dei più popolari stocks
Il prezzo per RNLX Attivo B Capitalizzazione del mercato a B Risultati
Renalytix Plc Renalytix Plc
$127,434 $6.43M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +84,842,529.76%
Renalytix Plc Renalytix Plc
$104,951 $6.43M
Apple Inc. Apple Inc.
AAPL
$4.490T +69,874,140.80%
Renalytix Plc Renalytix Plc
$97,293.38 $6.43M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +64,775,785.05%
Renalytix Plc Renalytix Plc
$85,931.96 $6.43M
Microsoft Corporation Microsoft Corporation
MSFT
$3.676T +57,211,588.86%
Renalytix Plc Renalytix Plc
$66,220.41 $6.43M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.833T +44,088,054.43%